Hardian Health’s Post

👀 Large Language Models (LLMs) still haven't received the green light for use in healthcare. The FDA’s latest opinion piece highlights a key point: no LLMs have received regulatory authorisation anywhere in the world. With their complexity and potential to reshape healthcare, there’s an ongoing debate on how they should be regulated. Key takeaways include: 1️⃣ Special mechanisms are needed to evaluate LLMs effectively in healthcare 2️⃣ Transparency and rigorous post-market monitoring are essential to ensuring patient safety 3️⃣ Collaboration across developers, regulators, and clinicians will be crucial to get this right As the conversation unfolds, the focus remains on bringing these tools to healthcare responsibly and safely. Read the full article ➡️ https://lnkd.in/eXtikgzb If you’d like to stay up to date with all things AI and regulation, sign up to the Hardian newsletter ➡️ https://lnkd.in/eaF6MMWs #HardianHealth #Regulation #Startups #HealthTech #DigitalHealth

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics